Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

United Therapeutic (UTHR)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,560,642
  • Shares Outstanding, K 43,722
  • Annual Sales, $ 1,628 M
  • Annual Income, $ 589,200 K
  • 60-Month Beta 1.10
  • Price/Sales 2.65
  • Price/Cash Flow 6.89
  • Price/Book 1.54

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/19
See More
  • Average Estimate 2.64
  • Number of Estimates 3
  • High Estimate 2.99
  • Low Estimate 2.18
  • Prior Year 5.57
  • Growth Rate Est. (year over year) -52.60%

Price Performance

See More
Period Period Low Period High Performance
1-Month
98.18 +5.42%
on 04/22/19
122.17 -15.28%
on 03/25/19
-17.30 (-14.32%)
since 03/22/19
3-Month
98.18 +5.42%
on 04/22/19
128.94 -19.73%
on 03/01/19
-10.80 (-9.45%)
since 01/24/19
52-Week
98.18 +5.42%
on 04/22/19
130.00 -20.38%
on 08/17/18
-6.55 (-5.95%)
since 04/24/18

Most Recent Stories

More News
United Therapeutics (UTHR) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

United Therapeutics (UTHR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

UTHR : 103.50 (-0.78%)
Look for Shares of United Therapeut to Potentially Rebound after Yesterday's 1.79% Sell Off

United Therapeut (NASDAQ:UTHR) traded in a range yesterday that spanned from a low of $98.54 to a high of $100.18. Yesterday, the shares fell 1.8%, which took the trading range below the 3-day low of...

UTHR : 103.50 (-0.78%)
SmarTrend Watching for Potential Rebound in Shares of United Therapeut After 1.79% Loss

United Therapeut (NASDAQ:UTHR) traded in a range yesterday that spanned from a low of $98.54 to a high of $100.18. Yesterday, the shares fell 1.8%, which took the trading range below the 3-day low of...

UTHR : 103.50 (-0.78%)
United Therapeutics Issues Statement In Response To Meritless Lawsuit

United Therapeutics Corporation (Nasdaq: UTHR) was named as a defendant, along with Smiths Medical ASD, Inc., in a lawsuit filed in federal court by Sandoz Inc. and RareGen, LLC on April 16, 2019. The...

UTHR : 103.50 (-0.78%)
Biotech Stock Roundup: AMGN's Evenity Earns FDA Approval, Deal Wins & More

Key highlights of the past week are new drug approvals, collaborations and pipeline updates.

CELG : 93.10 (-0.61%)
ALNY : 85.37 (-2.33%)
GILD : 62.80 (-0.38%)
REGN : 340.46 (-1.07%)
AMGN : 178.30 (-0.81%)
UTHR : 103.50 (-0.78%)
United Therapeutics Discontinues PAH Drug After Study Fails

United Therapeutics (UTHR) discontinues the development of esuberaprost, as the phase III study fails to meet primary endpoint.

ESALY : 57.6700 (-0.59%)
LLY : 118.00 (+0.43%)
UTHR : 103.50 (-0.78%)
BSTC : 64.41 (+0.75%)
Company News For Apr 9, 2019

Companies In The News Are: SNE, DLTR, UTHR, TWOU

DLTR : 110.21 (+0.83%)
SNE : 46.46 (-3.81%)
TWOU : 61.85 (-0.21%)
UTHR : 103.50 (-0.78%)
United Therapeut Set to Possibly Rebound After Yesterday's Selloff of 4.44%

United Therapeut (NASDAQ:UTHR) traded in a range yesterday that spanned from a low of $114.90 to a high of $117.15. Yesterday, the shares fell 4.4%, which took the trading range below the 3-day low of...

UTHR : 103.50 (-0.78%)
Look for Shares of United Therapeut to Potentially Rebound after Yesterday's 4.44% Sell Off

United Therapeut (NASDAQ:UTHR) traded in a range yesterday that spanned from a low of $114.90 to a high of $117.15. Yesterday, the shares fell 4.4%, which took the trading range below the 3-day low of...

UTHR : 103.50 (-0.78%)
United Therapeutics Announces BEAT Study of Esuberaprost Does Not Meet Primary Endpoint

United Therapeutics Corporation (Nasdaq: UTHR) today announced that the BEAT clinical study of esuberaprost tablets in patients suffering from pulmonary arterial hypertension did not meet its primary endpoint...

UTHR : 103.50 (-0.78%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators mostly agree with the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Trade UTHR with:

Business Summary

United Therapeutics Corporation is a biotechnology company focused on the development and commercialization of innovative products to address the unmet medical needs of patients with chronic and life-threatening conditions. United Therapeutics (UT) has an overarching commitment to environmental sustainability....

See More

Key Turning Points

2nd Resistance Point 105.17
1st Resistance Point 104.33
Last Price 103.50
1st Support Level 102.64
2nd Support Level 101.79

See More

52-Week High 130.00
Fibonacci 61.8% 117.84
Fibonacci 50% 114.09
Fibonacci 38.2% 110.34
Last Price 103.50
52-Week Low 98.18

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar